David Knapp

David Knapp

Dave Knapp, vice president, Corporate Research, Boston Scientific, has been working to treat unmet needs in coronary, cardiovascular and pulmonary medicine for 20 years.  At Boston Scientific, Dave leads initiatives to drive innovation and new growth in white space areas and expand to new geographies.  One of his key areas of focus has been coordinating open collaborative efforts, including developing relationships with external institutions and connecting across disciplines and functions to drive meaningful innovation. Dave has held a number of roles within Boston Scientific, spanning from development efforts in drug-eluting stents to exploratory and  commercialization phases of the development cycle for various medical technologies in the cardiovascular space. He is an author on a number of publications in the areas of biopolymer rheology, in vitro assays for cell migration and traction, and modeling mechanisms of release from controlled release formulations. He holds a Bachelor of Science in chemical engineering from the University of Michigan, Ann Arbor and a Ph.D. in Chemical Engineering from the Department of Chemical Engineering and Materials Science of the University of Minnesota.